Kidney Cancer

Hemodialysis Ups Kidney Cancer Death Risk

By

Jody A. Charnow

Publish Date July 10, 2020

Among patients with renal cell carcinoma, those on hemodialysis have a 5 times higher risk of dying from the cancer than those not on dialysis, a study found.

Cytoreductive Nephrectomy in mRCC Does Not Improve Survival, Real-World Study Finds

By

Natasha Persaud

Publish Date July 1, 2020

In a real-world study, cytoreductive nephrectomy (CN) prior to treatment with tyrosine kinase inhibitors did not improve survival for CN recipients overall, but did improve cancer-specific and progression-free survival in certain subgroups.

Positive vs Negative Lymph Nodes Portend Worse Prognosis in Stage 3 RCC

By

Natasha Persaud

Publish Date June 15, 2020

In a study involving stage 3 RCC patients, those with positive lymph nodes had markedly inferior 5-year survival compared with those with lymph-node negative disease and 5-year survival similar to those with stage 4 RCC.

Prioritizing Urologic Cancer Cases During the COVID-19 Pandemic

By

Natasha Persaud

Publish Date June 2, 2020

Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.

Death Rate From Low-Risk RCC Rises With Age Regardless of Treatment Modality

By

Jody A. Charnow, Editor

Publish Date May 18, 2020

Among patients who undergo treatment for T1a renal cell carcinoma, 5- and 10-year cancer-specific mortality rates rise with age across treatment modalities, a study found.